Logo image
Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy
Journal article   Open access   Peer reviewed

Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy

Michael Arad, Ivan P Moskowitz, Vickas V Patel, Ferhaan Ahmad, Antonio R Perez-Atayde, Douglas B Sawyer, Mark Walter, Guo H Li, Patrick G Burgon, Colin T Maguire, …
Circulation (New York, N.Y.), Vol.107(22), pp.2850-2856
06/10/2003
DOI: 10.1161/01.CIR.0000075270.13497.2B
PMID: 12782567
url
https://doi.org/10.1161/01.CIR.0000075270.13497.2BView
Published (Version of record) Open Access

Abstract

Mutations in the gamma2 subunit (PRKAG2) of AMP-activated protein kinase produce an unusual human cardiomyopathy characterized by ventricular hypertrophy and electrophysiological abnormalities: Wolff-Parkinson-White syndrome (WPW) and progressive degenerative conduction system disease. Pathological examinations of affected human hearts reveal vacuoles containing amylopectin, a glycogen-related substance.
Mutation Glycogen Storage Disease - complications Wolff-Parkinson-White Syndrome - physiopathology Humans Multienzyme Complexes - metabolism AMP-Activated Protein Kinases Cardiomyopathies - physiopathology Glycogen Storage Disease - pathology Electrocardiography Glycogen Storage Disease - physiopathology Protein-Serine-Threonine Kinases - metabolism Disease Models, Animal Protein-Serine-Threonine Kinases - genetics Cardiomyopathies - pathology Mice, Transgenic Myocardium - pathology Survival Rate Wolff-Parkinson-White Syndrome - pathology Multienzyme Complexes - genetics Protein-Serine-Threonine Kinases - biosynthesis Wolff-Parkinson-White Syndrome - etiology Animals Heart Conduction System - physiopathology Cardiomyopathies - complications Multienzyme Complexes - biosynthesis Mice Electrophysiologic Techniques, Cardiac

Details

Metrics

Logo image